CONCORDE ASSET MANAGEMENT, LLC – Protagenic Therapeutics, Inc. Transaction History
CONCORDE ASSET MANAGEMENT, LLC portfolio value:
$10,000
portfolio value
CONCORDE ASSET MANAGEMENT, LLC quarter portfolio value change:
-21.13%
quarter
Protagenic Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +34.63% | 4.3K shares | 1K | $0.57 | 16.71K |
| Q2 2022 | share | Increase | 0.00% | 12.41K shares | 9K | $0.72 | 12.41K |